Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

DL-Glutamic acid

Base Information Edit
  • Chemical Name:DL-Glutamic acid
  • CAS No.:56-86-0
  • Molecular Formula:C5H9NO4
  • Molecular Weight:147.131
  • Hs Code.:2922421000
  • European Community (EC) Number:210-522-2
  • NSC Number:206301,620337,143503,77686,9967
  • UNII:61LJO5I15S
  • DSSTox Substance ID:DTXSID0046987
  • Nikkaji Number:J5.177B
  • Wikidata:Q181136,Q27145702
  • NCI Thesaurus Code:C81373
  • Mol file:56-86-0.mol
DL-Glutamic acid

Synonyms:Aluminum L Glutamate;Aluminum L-Glutamate;D Glutamate;D-Glutamate;Glutamate;Glutamate, Potassium;Glutamic Acid;Glutamic Acid, (D)-Isomer;L Glutamate;L Glutamic Acid;L-Glutamate;L-Glutamate, Aluminum;L-Glutamic Acid;Potassium Glutamate

Suppliers and Price of DL-Glutamic acid
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
Total 350 raw suppliers
Chemical Property of DL-Glutamic acid Edit
Chemical Property:
  • Appearance/Colour:White cryst. powder 
  • Vapor Pressure:0mmHg at 25°C 
  • Melting Point:205 °C (dec.)(lit.) 
  • Refractive Index:1.508 
  • Boiling Point:333.783 °C at 760 mmHg 
  • Flash Point:155.667 °C 
  • PSA:100.62000 
  • Density:1.41 g/cm3 
  • LogP:-0.03660 
  • Water Solubility.:7.5 g/L (20℃) 
  • XLogP3:-3.7
  • Hydrogen Bond Donor Count:3
  • Hydrogen Bond Acceptor Count:5
  • Rotatable Bond Count:4
  • Exact Mass:147.05315777
  • Heavy Atom Count:10
  • Complexity:145
Purity/Quality:

min 99% *data from raw suppliers

Safty Information:
  • Pictogram(s): IrritantXi 
  • Hazard Codes:Xi 
  • Safety Statements: S24/25:; 
MSDS Files:

SDS file from LookChem

Total 1 MSDS from other Authors

Useful:
  • Chemical Classes:Biological Agents -> Amino Acids and Derivatives
  • Canonical SMILES:C(CC(=O)O)C(C(=O)O)N
  • Recent ClinicalTrials:Effects of Dietary Amino Acids on Serum and Macrophage Atherogenicity
  • Biological Functions Glutamic acid serves as a fundamental excitatory neurotransmitter in the central nervous system, playing a crucial role in cognitive and sensorimotor functions. It is essential for brain functions and homeostasis.
  • Role in Plant Development Glutamic acid contributes to the development of chlorophyll molecules and is involved in carbohydrate anabolism. It aids in the synthesis of growth materials akin to plant hormones, promoting plant growth and adapting to environmental conditions.
  • Food Industry Importance L-glutamic acid, a non-essential amino acid, is naturally present in various foods either in free form or bound with proteins. It is extracted from sources like wheat gluten, soybean meal, and casein, or produced through microbial fermentation. In the food industry, it serves as a flavor-enhancing additive, commonly known as monosodium glutamate (MSG), added to foods such as soups, meats, seasonings, snacks, and sauces for taste enhancement.
  • Role as Precursor L-glutamic acid acts as a precursor for the synthesis of proline, an essential amino acid crucial for collagen structure.
  • Metabolism in Living Organisms Being an amino acid, L-glutamic acid can be easily metabolized by living organisms in soil and plants.
  • pH-sensitive Properties Glutamic acid exhibits distinctive pH-sensitive properties, existing in different forms such as zwitterions, glutamate anions, and double-negative anions depending on the pH of the environment.
  • General Description L-Glutamic acid (alpha) is a key excitatory neurotransmitter in the central nervous system, playing a crucial role in neuronal signaling, synaptic plasticity, and memory consolidation. It serves as a precursor for the synthesis of various bioactive compounds, including glutamate receptor antagonists and agonists, which are explored for treating neurological disorders such as persistent pain, Alzheimer’s disease, epilepsy, and ischaemia. Its derivatives, including conformationally restricted analogues like 4-amino-4-carboxyproline and phosphinic analogues, are studied for their receptor specificity and therapeutic potential. Additionally, L-glutamic acid is utilized as a chiral template in stereocontrolled polymer synthesis, contributing to the development of crystalline polyamides. Its structural versatility enables applications in medicinal chemistry, neuroprotection, and the synthesis of bioactive molecules targeting glutamate receptors.
Technology Process of DL-Glutamic acid

There total 363 articles about DL-Glutamic acid which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
With marine bivalve lysozyme; MOPS buffer; Tapes japonica; at 37 ℃; pH=7.0; Enzyme kinetics;
DOI:10.1007/s00018-003-3082-z
Guidance literature:
With soybean cotyledon N-terminal acidic amino acid-specific aminopeptidase; at 37 ℃; pH=7.2; aq. HEPES buffer; Enzymatic reaction;
DOI:10.1271/bbb.90617
Refernces Edit

Extension of the "ring switch" approach to glutamate antagonists to δ-lactam urethanes

10.1039/b207936d

The research focuses on the extension of the "ring switch" approach to the synthesis of glutamate antagonists, specifically utilizing δ-lactam urethanes. The study successfully employed three different types of δ-lactam urethane aldehydes (17, 26, and 59) in the synthesis process, manipulating diastereoisomeric ratios through the use of a hindered proton source to obtain homochiral products with two chiral centers. Although the δ-lactam urethane system was less versatile compared to pyroglutamate or β-lactam urethanes, the research managed to prepare a variety of glutamate antagonist homologues. The experiments involved the synthesis of compounds that mimic glutamate, the fast excitatory receptor in the brain, and are potentially useful in treating illnesses such as persistent pain, Alzheimer’s disease, epilepsy, and ischaemia. The methodology, referred to as a "ring switching" reaction, allows for the economical preparation of a large variety of homochiral compounds. The analyses used in the study included various spectroscopic techniques and chromatography to confirm the structures and purities of the synthesized compounds.

Determination of the absolute configuration of phosphinic analogues of glutamate

10.1039/c4ob01960a

The research focuses on the determination of the absolute configuration of phosphinic analogues of glutamate, specifically LSP1-2111, which are known to be potent agonists of metabotropic glutamate (mGlu) receptors and have shown promising in vivo activity. The study aimed to separate the mixture of two diastereomers of LSP1-2111, whose absolute and relative configurations were previously unknown, using a Crownpack CR(+) column. The absolute configuration was assessed through a diastereoselective synthesis involving various reactants such as phosphinic acid, 3-nitrobenzaldehydes, and amino acids. The experiments included radical processes, condensation, acid hydrolysis, and the use of chiral HPLC for separation. The analysis involved optical rotation, 1H NMR, 31P NMR, and X-ray crystallography to characterize the diastereomers and determine their absolute configuration. The study also investigated the biological activity of the separated L-stereomers, finding that they activated the mGlu4 receptor with varying EC50 values.

Novel isothiourea derivatives as potent neuroprotectors and cognition enhancers: synthesis, biological and physicochemical properties

10.1021/jm8012882

The study focuses on the synthesis, biological, and physicochemical properties of novel isothiourea derivatives, specifically 3-allyl-1,1-dibenzyl-2-ethyl-isothiourea salts (1: hydrochloride, 2: hydrobromide, and 3: hydroiodide), which were developed as potential neuroprotectors and cognition enhancers. These compounds were evaluated for their ability to inhibit glutamate-stimulated calcium ion uptake in rat brain synaptosomes, interact with NMDA receptors, and their effects on AMPA receptor transmembrane currents induced by kainic acid and glutamate in Purkinje neurons. The study also included the growth of single crystals and X-ray diffraction experiments to determine the crystal structures of these salts, analysis of their solubility and partitioning properties in water and n-octanol, and assessment of their chemical stability in pH 7.4 phosphate buffer at 25 °C. The main purpose of these chemicals was to investigate their potential as therapeutic agents for neurological disorders by targeting ionotropic glutamate receptors, which play crucial roles in neuronal signaling, memory consolidation, and synaptic plasticity.

Intramolecular nicholas reaction: Stereoselective synthesis of 5-alkynylproline derivatives

10.1021/ol800544a

The study focuses on the intramolecular Nicholas reaction, a method for the stereoselective synthesis of 5-alkynylproline derivatives, which are important structural components in natural and bioactive products. The researchers used N,N-acyl-diprotected ω-semialdehydes derived from glutamic acid as starting materials. Key chemicals involved in the process include propargylic alcohols, Co2(CO)6 (a cobalt complex used for complexation), and various N-protecting groups such as tosyl and benzoyl derivatives. These chemicals served the purpose of controlling the stereochemistry during the ring formation, allowing for the selective synthesis of specific isomers of 5-alkynylproline derivatives. The study also utilized semiempirical calculations to support the observed stereochemistry and to understand the influence of different N-protecting groups on the cyclization reaction. The goal was to develop a practical method for constructing 2,5-dialkylpyrrolidines in their enantiomeric forms, which are versatile intermediates for the synthesis of a wide variety of related molecules.

Stereocontrolled synthesis of stereoregular, chiral analogs of nylon 5,5 and nylon 5,6

10.1016/S0957-4166(97)00121-3

The research aimed to develop a stereocontrolled synthesis method for producing stereoregular, chiral analogs of nylon 5,5 and nylon 5,6, utilizing L-glutamic acid as a chiral template. The study focused on achieving stereocontrol in the synthesis of these polymers through chemoselective condensation of the ester group with aminoalcohols, leading to the formation of N-(hydroxyalkyl)amides. These amides were further functionalized by converting the alcohol function into an amine through a series of reactions involving tosylation, azide substitution, and hydrogenolysis. The resulting amino lactones were then used in polycondensation to yield the final crystalline polyamides. The chemicals used in this process included L-glutamic acid, pentachlorophenyl ester, aminoalcohols, ethyldiisopropylamine (EDPA), tosyl chloride, sodium azide, and palladium on carbon for hydrogenolysis, among others. The conclusions of the research were that the synthesized polyamides displayed high optical rotation values, indicating their stereoregularity, and were highly crystalline as confirmed by X-ray diffraction and DSC analysis.

Two prodrugs of potent and selective GluR5 kainate receptor antagonists actives in three animal models of pain

10.1021/jm0491952

The research aimed to develop potent and selective GluR5 kainate receptor antagonists for the treatment of pain. The study focused on two competitive GluR5 KA receptor antagonists, amino acids 5 and 7, which showed high affinity for the GluR5 receptor over other glutamate receptors. Their ester prodrugs, 6 and 8, were tested for oral activity in three animal models of pain: formalin-induced paw licking, carrageenan-induced thermal hyperalgesia, and capsaicin-induced mechanical hyperalgesia. The synthesis involved various steps such as selective removal of methyl carbamate protecting groups, reduction of ketones, Mitsunobu reactions, and tetrazole formation. The study concluded that prodrugs 6 and 8 demonstrated oral efficacy in the three animal models of pain, suggesting their potential as treatments for pain conditions.

Novel synthesis of 2-aminopentanedinitriles from 2-(bromomethyl)aziridines and their transformation into 2-imino-5-methoxypyrrolidines and 5-methoxypyrrolidin-2-ones

10.1016/j.tet.2007.03.116

The research focuses on the novel synthesis of 2-aminopentanedinitriles from 2-(bromomethyl)aziridines and their subsequent transformation into 2-imino-5-methoxypyrrolidines and 5-methoxypyrrolidin-2-ones. The study explores an unprecedented reaction mechanism involving base-induced ring opening of intermediate 2-(cyanomethyl)aziridines into allylamines, followed by migration of the double bond towards aldimines via enamine intermediates. The synthesized aminopentanedinitriles serve as precursors for the preparation of glutamic acid derivatives, which are significant in the central nervous system as excitatory neurotransmitters. The experiments utilized reactants such as 1-arylmethyl-2-(bromomethyl)aziridines, potassium cyanide in DMSO, and sodium methoxide in methanol. The analyses included column chromatography for purification, and various spectroscopic techniques such as NMR, IR, and MS for structural characterization and confirmation of the synthesized compounds.

Asymmetric syntheses of all four isomers of 4-amino-4-carboxyproline: Novel conformationally restricted glutamic acid analogues

10.1016/0957-4166(95)00209-8

The study focuses on the asymmetric synthesis of all four isomers of 4-amino-4-carboxyproline, which are novel conformationally restricted analogues of glutamic acid. The researchers used trans-4-hydroxy-L-proline as the homochiral starting material and employed the Bucherer-Bergs reaction as the key step to form spirohydantoin rings. The study resulted in the successful synthesis of the target compounds (2S,4S)-3, (2S,4R)-4, and their corresponding enantiomers, with high enantiomeric purity (e.e. >95%). The structures and stereochemistries of these compounds were determined and confirmed using NMR studies, including NOE measurements and 1H-NMR spectra analyses.

Stereoselective synthesis of (5S,6S)- and (5S,6R)-aza-muricatacin from an L-glutamic acid derivative

10.1016/S0957-4166(01)00251-8

Muricatacin is a bioactive hydroxy lactone compound that is isolated from the plant Annona muricata. It is mentioned in the research as a compound with physiological activity. The study focuses on the synthesis of aza-muricatacin, a non-natural aza-analogue of muricatacin, which also exhibits interesting cytotoxic activity. The research aims to synthesize different diastereoisomers of aza-muricatacin, specifically the (5S,6S)- and (5S,6R)-isomers, starting from a common precursor derived from L-glutamic acid.

Post RFQ for Price